Pharmaceuticals in the United Kingdom

November 2025 | 41 pages | ID: P2BD94DCDE20EN
MarketLine

Abstracts

Summary

Pharmaceuticals in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

• The pharmaceutical market includes sales of both prescriptions and over-the-counter (OTC) drugs. The market scope does not cover consumer healthcare and animal health products.
• The UK pharmaceuticals market recorded revenues of $55.3 billion in 2024, representing a compound annual growth rate (CAGR) of 5.8% between 2019 and 2024.
• The oncology drugs segment accounted for the market's largest proportion in 2024, with total revenues of $7.0 billion, equivalent to 12.6% of the market's overall value.
• The UK pharmaceuticals market witnessed strong growth in 2024, registering an annual growth of 7.7%.

Scope

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in the United Kingdom
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the United Kingdom
• Leading company profiles reveal details of key pharmaceuticals market players? global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the United Kingdom pharmaceuticals market with five year forecasts

Reasons to Buy

• What was the size of the United Kingdom pharmaceuticals market by value in 2024?
• What will be the size of the United Kingdom pharmaceuticals market in 2029?
• What factors are affecting the strength of competition in the United Kingdom pharmaceuticals market?
• How has the market performed over the last five years?
• What are the main segments that make up the United Kingdom's pharmaceuticals market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Category segmentation
4.2. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Who are the leading players?
7.2. What are the strengths of leading players?
7.3. What are the recent developments in the market?

8 COMPANY PROFILES

8.1. Novartis AG
8.2. AstraZeneca Plc
8.3. GSK plc

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List Of Tables

LIST OF TABLES

Table 1: United Kingdom pharmaceuticals market value: $ million, 2019-24
Table 2: United Kingdom pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 3: United Kingdom pharmaceuticals market category segmentation: $ million, 2019-24
Table 4: United Kingdom pharmaceuticals market geography segmentation: $ million, 2024
Table 5: United Kingdom pharmaceuticals market value forecast: $ million, 2024-29
Table 6: Novartis AG: Key Facts
Table 7: Novartis AG: Annual Financial Ratios
Table 8: Novartis AG: Key Employees
Table 9: AstraZeneca Plc: Key Facts
Table 10: AstraZeneca Plc: Annual Financial Ratios
Table 11: AstraZeneca Plc: Key Employees
Table 12: GSK plc: Key Facts
Table 13: GSK plc: Annual Financial Ratios
Table 14: GSK plc: Key Employees
Table 15: United Kingdom Size of Population (Million), 2020-24
Table 16: United Kingdom Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 17: United Kingdom GDP (Current Prices, $ Billion), 2020-24
Table 18: United Kingdom Inflation, 2020-24
Table 19: United Kingdom Consumer Price Index (Absolute), 2020-24
Table 20: United Kingdom Exchange Rate, 2019-24

List Of Figures

LIST OF FIGURES

Figure 1: United Kingdom pharmaceuticals market value: $ million, 2019-24
Figure 2: United Kingdom pharmaceuticals market category segmentation: $ million, 2019-24
Figure 3: United Kingdom pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 4: United Kingdom pharmaceuticals market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the pharmaceuticals market in the United Kingdom, 2024
Figure 6: Drivers of buyer power in the pharmaceuticals market in the United Kingdom, 2024
Figure 7: Drivers of supplier power in the pharmaceuticals market in the United Kingdom, 2024
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United Kingdom, 2024
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in the United Kingdom, 2024
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in the United Kingdom, 2024